Relationship between glutathione S-transferase M1 deficiency and urothelial cancer in dye workers exposed to aromatic amines

Journal of Urology

Volumn 159, Issue 2, 1998, Pages 380-383

  Shinka, Toshiaki ^a   Ogura, Hideaki ^a   Morita, Teruo ^a   Nishikawa, Toru ^a   Fujinaga, Takuji ^a   Ohkawa, Tadashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Arylamine; Epidemiology, molecular; Glutathione transferases; Occupational exposure; Urologic neoplasms

Indexed keywords

CARCINOGEN; DYE; NITROSAMINE;

ARTICLE; CARCINOGENICITY; DETOXIFICATION; DISEASE ASSOCIATION; ENZYME DEFICIENCY; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; URINARY TRACT CANCER; UROTHELIUM;

EID: 0031964548     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63924-7     Document Type: Article

References (12)

1. Murray, R. K., Granner, D. K., Mayes, P. A. and Rodwell, V. W.: Metabolism of xenobiotics. In: Harper's Biochemistry, 23rd ed. Connecticut: Appleton & Lange, pp. 704-709, 1993.
2. Rehn, L.: Blasengeschwülste bei Fuchsin-Arbeitern. Arch. Klin. Chir., 50: 588, 1895.
3. Hueper, T.: Experimental production of bladder tumours in dogs by administration of beta-naphthylamine. J. Indust. Hyg. Toxicol., 20: 46, 1938.
4. Case, R. A. M., Hosker, M. E. and McDonald, D. B.: Tumours of the urinary bladder in workmen engaged in manufacture and use of certain dyestuff intermediates in the British chemical industry. Brit. J. Indust. Med., 11: 75, 1954.
5. Shinka, T., Sawada, Y., Morimoto, S., Fujinaga, T., Nakamura, J. and Ohkawa, T.: Clinical study on urothelial tumors of dye workers in Wakayama City. J. Urol., 146: 1504, 1991.
6. Shinka, T., Miyai, M., Sawada, Y., Inagaki, T. and Okawa, T.: Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines. Int. J. Urol., 2: 243, 1995.
7. Hirvonen, A.: Genetic factors in individual responses to environmental exposures. J. Occup. Environ. Med., 37: 37, 1995.
8. Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L. and Lucier, G. W.: Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst., 85: 1159, 1993.
9. Brockmöller, J., Kerb, R., Drakoulis, N., Staffeldt, B. and Roots, I.: Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res., 54: 4103, 1994.
10. Daly, A. K., Thomas, D. J., Cooper, J., Pearson, W. R., Neal, D. E. and Idle, J. R.: Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. Brit. Med. J., 307: 481, 1993.
11. Lin, H. J., Han, C. Y., Bernstein, D. A., Hsiao, W., Lin, B. K. and Hardy, S.: Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis, 15: 1077, 1994.
12. Nakachi, K., Imai, K., Hayashi, S. and Kawajiri, K.: Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994, 1993.